Skip to main content

Market Overview

Mid-Morning Market Update: Markets Rise; Lennox Beats Q1 Views

Share:

Following the market opening Monday, the Dow traded up 0.22% to 34,117.37 while the NASDAQ rose 0.37% to 14,068.08. The S&P also rose, gaining 0.31% to 4,193.15.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,077,470 cases with around 572,200 deaths. India confirmed a total of at least 17,313,160 cases and 195,120 deaths, while Brazil reported over 14,340,780 COVID-19 cases with 390,790 deaths. In total, there were at least 147,238,540 cases of COVID-19 worldwide with more than 3,110,510 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Financial shares climbed by 1.3% on Monday. Meanwhile, top gainers in the sector included Jiayin Group Inc. (NASDAQ: JFIN), up 29%, and Atlantic Capital Bancshares, Inc. (NASDAQ: ACBI), up 7%.

In trading on Monday, consumer staples shares fell 0.9%.

Top Headline

Lennox International Inc. (NYSE: LII) reported stronger-than-expected results for its first quarter.

Lennox reported quarterly earnings of $2.27 per share, beating analysts’ estimates of $1.31 per share. The company’s quarterly sales came in at $931.00 million, versus expectations of $790.95 million.

Lennox International raised FY21 adjusted EPS guidance from $10.55-$11.15 to $11.40-$12.00.
The company also raised sales growth guidance from 4-8% to 7-11%.

Equities Trading UP

Proofpoint, Inc. (NASDAQ: PFPT) shares shot up 32% to $173.53. Private equity investment firm Thoma Bravo Advantage inked an agreement to acquire cybersecurity and compliance company Proofpoint in an all-cash transaction valuing Proofpoint at $12.3 billion.

Shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) got a boost, shooting 50% to $6.38 after the company announced the full details of its Phase 2 trial evaluating its lead drug candidate, RP5063 (brilaroxazine), for Acute Schizophrenia. Brilaroxazine demonstrated high affinity and selectivity for key serotonin receptors (5-HT1A/2A/2B/7) through its combination of potent affinity and selectivity for target receptors implicated for schizophrenia and its comorbid symptoms.

Casper Sleep Inc. (NYSE: CSPR) shares were also up, gaining 26% to $8.85 after Wedbush upgraded the stock from Neutral to Outperform and raised its price target from $10 to $10.50per share.

Check out these big movers of the day

Equities Trading DOWN

Sypris Solutions, Inc. (NASDAQ: SYPR) shares tumbled 15% to $3.785 after jumping 59% on Friday.

Shares of Uxin Limited (NASDAQ: UXIN) were down 14% to $1.8599. The company, last week, announced it entered a partnership with JD.com to "launch a self-operated online store for used car transactions through JD's platform."

Fortuna Silver Mines Inc. (NYSE: FSM) was down, falling 13% to $6.71. Fortuna Silver Mines and Roxgold entered into a merger agreement.

Commodities

In commodity news, oil traded down 1.4% to $61.27, while gold traded up 0.1% to $1,779.40.

Silver traded up 0.1% Monday to $26.19 while copper rose 1.9% to $4.4160.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.1%, the Spanish Ibex Index rose 0.5% and the German DAX 30 dropped 0.3%. Meanwhile, the French CAC 40 fell 0.1% London’s FTSE 100 fell 0.1% and Italy’s FTSE MIB gained 0.1%.

German Ifo Business Climate indicator increased slightly to 96.8 in April from the previous month's level of 96.6. Spain's producer price inflation increased to 6.3% year-over-year in March.

Economics

US durable goods orders rose 0.5% for March.

The Dallas Fed manufacturing index for April is scheduled for release at 10:30 a.m. ET.

The Treasury is set to auction 6-month bills and 2-year notes at 11:30 a.m. ET.

The Treasury will auction 3-month bills and 5-year notes at 1:00 p.m. ET.

Check out the full economic calendar here

 

Related Articles (ACBI + CSPR)

View Comments and Join the Discussion!

Posted-In: Earnings News Penny Stocks Eurozone Commodities Small Cap Global Intraday Update

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com